Additional Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Los Angeles CA. 90033
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Detroit MI. 48202
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Phoenix AZ. 85006
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Stanford CA. 94305
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Birmingham AL. 35205
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Champaign IL. 61820
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Lexington KY. 40536
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Saint-Charles-Borromée QC. J6E 2B4
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Baltimore MD. 21201
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Chicago IL. 60611
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Sacramento CA. 95817
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Loma Linda CA. 92350
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Phoenix AZ. 85032
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Philadelphia PA. 19140
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Kansas City KS. 66160
    View Details

  • A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

    Pasadena Center for Medical Research, Inc
    St. Petersburg FL. 33707
    View Details

  • A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

    Clinical Research of Rock Hill
    Rock Hill SC. 29732
    View Details

  • A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

    Tennessee Comprehensive Lung and Sleep Center
    Hendersonville TN. 37075
    View Details

  • A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

    SEC Clinical Research LLC
    Dothan AL. 36305
    View Details

  • A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

    Hannibal Regional Healthcare System, Inc.
    Hannibal MO. 63401
    View Details